ANRESIS, the Swiss Centre for Antibiotic Resistance is a nationwide, representative surveillance system and research instrument for antibiotic resistance and consumption. It is led by the Institute for Infectious Diseases (IFIK) of the University of Bern and is financially supported by the Swiss Federal Office of Public Health (FOPH) and the IFIK.
In our latest publication (https://www.anresis.ch/wp-content/uploads/2023/08/2023_patient-specific_ACD_Renggli_JAC.pdf) we show the feasibility of automatically converting electronic medical record data into antibiotic stewardship indicators.
Our study on the burden of AMR in Switzerland has just been published in Eurosurveillance https://www.anresis.ch/wp-content/uploads/2023/05/2023_burden_eurosurveillance.pdf. We found a significant increase in infections, years of life lost and deaths due to antibiotic-resistant bacteria between 2010 and 2019.
Data from ANRESIS show, that species distribution and resistance profiles differ significantly between catheter-associated and non-catheter-associated urinary tract infections.
https://www.anresis.ch/wp-content/uploads/2023/03/2023_CAUTI_Marschall_SHEA.pdf
ANRESIS continuously collects all anonymized resistance data that is generated in routine diagnostics from
ANRESIS is supported by the following Organisations
